APLN and type 2 diabetes mellitus: The results of our study can be concisely explained if there is a protective effect of apelin in T2DM patients with known HF on cardiac structure and function is a result of uncoupling between the concentration of apelin and expression of its corresponding receptor (G protein-coupled receptor, APJ) on the surfaces of target cells including cardiac myocytes [35].